PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193441
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1193441
Gene Editing Tools Market size was valued at USD 4,508.9 Million in 2021, expanding at a CAGR of 19.8% from 2023 to 2030.
Genome editing, also known as gene editing, is a form of genetic engineering in which the replacement and deletion of specific DNA from a specified spot within the genome of an organism or cell are the main goals. This is accomplished with the aid of artificial nucleases. Gene editing mostly uses specialized equipment and is typically carried out in various labs known as gene editing tools.
Market Dynamics
The significant factors driving the growth of the gene editing tools market are the rising prevalence of long-term chronic diseases like Alzheimer's, heart disease, diabetes, and cancer among others, as well as the rising efficiency and effectiveness of genome editing methods made possible by these tools. Additionally, the market's overall growth is accelerated by the expanding fields of use for genome editing. The U.K.'s growing desire to improve agricultural production and the growth of gene editing research are two factors that are expected to drive the Europe market. Another important element that is anticipated to contribute to the rise is the rising prevalence of rare diseases in the nation. However, the difficulties brought on by the patent litigation involving the many businesses is hampering the market growth.
Rising market prospects are anticipated as a result of increased spending in scientific research and development and life sciences. On the other hand, the expansion of the market may be hampered by the lack of information and expertise about these technologies, particularly in developing nations. Additionally, the growing number of clinical trials being done to offer cutting-edge stem cell and gene therapies will fuel demand in the United States. The Retron Library Recombineering (RLR) method, a new genome editing approach, was successfully created in May 2023 by researchers at Harvard's Wyss Institute for Biologically Inspired Engineering.
Segmentation Analysis:
The Global Gene Editing Tools Market is segmented on the basis of Product, Application, End User, and Region.
The market is split into six categories based on Product: CRISPR/Cas9, ZFNs, TALENs, viral systems, transposon systems, others. The CRISPR segment dominates the market. CRISPR editing tools are used by scientists in research field is mainly contributing to segment growth.
The market is segmented into seven categories based on application: veterinary medicine, cell line engineering, bioremediation, food and brewing development, food waste management, bio sensing development, and others. The cell line engineering segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to a rise in the demand for genome engineering.
The market is segmented into four categories based on end user: Academic research, Food industry, pharma & biotech, and others. The academic research segment dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the number of research project activities in gene editing is boosting the segment growth.
Competitive Landscape:
The worldwide market for gene editing tools is vastly fragmented in nature which comprised of large and small-sized market players with few large dominating the global market share. The companies in market emphasize on adopting aggressive strategies to reach out large consumer base. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new Product launches, partnerships, distribution network development, R&D spending, and mergers and acquisitions.
For instance, in April 2023, CANbridge Pharmaceuticals, Inc., one of the top biopharmaceutical companies, collaborated with LogicBio Therapeutics, Inc., a clinical-stage genetic medicine company.
Key features of the study:
This proposed research study on Gene Editing Tools market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2023 as the base year
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Gene Editing Tools market
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Gene Editing Tools market
Impact of COVID-19 on Gene Editing Tools market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Gene Editing Tools market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Gene Editing Tools market, we have also included competitive landscape and key innovator analysis for the Gene Editing Tools market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Gene Editing Tools market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Gene Editing Tools market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL GENE EDITING TOOLS MARKET KEY PLAYERS
Thermo Fisher Scientific Inc.
CRISPR Therapeutics
Editas Medicine
National Human Genome Research Institute
Intellia Therapeutics, Inc
Merck KGaA
Horizon Discovery Ltd
GeneCopoeia Inc
ERS Genomics
Takara Bio Inc
New England Biolabs
GenScript
Lonza
Sangamo Therapeutics
LogicBio Therapeutics
GLOBAL GENE EDITING TOOLS MARKET, BY PRODUCT
CRISPR/Cas9
ZFNs
TALENs
Viral systems
Transposon systems
Others
GLOBAL GENE EDITING TOOLS MARKET, BY APPLICATION
Veterinary medicine
Cell line engineering
Bioremediation
Food and brewing development
Food waste management
Bio sensing development
Others
GLOBAL GENE EDITING TOOLS MARKET, BY END USER
Academic research
Food industry
Pharma & biotech
Others
GLOBAL GENE EDITING TOOLS MARKET, BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA